Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation

International Archives of Allergy and Immunology

Volumn 140, Issue SUPPL. 1, 2006, Pages 17-22

  Kushiya, Mariko ^a   Saito, Keiko ^a   Kikuchi, Izumi ^a   Kobayashi, Takehito ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a   Nagata, Makoto ^a,b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Department of Respiratory Medicine ^*  (Japan)

Author keywords

2 Agonist; Cell adhesion; Eosinophil; Leukotriene antagonist; Superoxide anion

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOCHROME C; EOSINOPHIL PEROXIDASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 5; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PHORBOL 13 ACETATE 12 MYRISTATE; SALBUTAMOL; SUPEROXIDE;

ADULT; ALLERGIC ASTHMA; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; BLOOD DONOR; CELL ACTIVATION; CELL ADHESION; CELL ASSAY; CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; LEUKOCYTE ADHERENCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ACETATES; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; CELL ADHESION; CELLS, CULTURED; EOSINOPHILS; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES; SUPEROXIDES;

EID: 33745072808     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092706     Document Type: Conference Paper

References (33)

1. Flood-Page PT, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112: 1029-1036.
2. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C: A critical role for eosinophils in allergic airways remodeling. Science 2004;305:1776-1779.
3. Lee JJ, Dimina D, Macias MP, Ochkur SI, Mcgarry MP, O'Neill KR, Protheroe C, Pero R, Nguyen T, Cormier SA, Lenkiewicz E, Colbert D, Rinaldi L, Ackerman SJ, Irvin CG, Lee NA: Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305:1773-1776.
4. Seymour ML, Rak S, Aberg D, Riise GC, Penrose JF, Kanaoka Y, Austen KF, Holgate ST, Sampson AP: Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics. Am J Respir Crit Care Med 2001;164:2051-2056.
5. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101: 834-846.
6. 4 and granulocytes infiltration into asthmatic airways. Lancet 1993;341:989-990.
7. 4 and methacholine inhalation in patients with asthma. Am J Respir Crit Care Med 2000;162:1685-1689.
8. 4, increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 2001;164:1495-1500.
9. 4 and methacholine on cell differentials in sputum from patients with asthma. Am J Respir Crit Care Med 1997;155: 1247-1253.
10. Nagata M, Saito K: The roles of cysteinyl leukotrienes in eosinophilic inflammation of asthmatic airways. Int Arch Allergy Immunol 2003;131:7-10.
11. 4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor. J Allergy Clin Immunol 2002;109:676-680.
12. 4 and eosinophil transendothelial migration, superoxide generation and degranulation via beta2 integrin. Ann Allergy Asthma Immunol 2004;93:594-600.
13. Braccioni F, Dorman SC, O'Byrne PM, Inman MD, Denburg JA, Parameswaran K, Baatjes AJ, Foley R, Gauvreau GM: The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 2002;110:96-101.
14. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994;55:183-199.
15. Lee E, Robertson T, Smith J, Kilfeather S: Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med 2000;161:1881-1886.
16. Bandeira-Melo C, Hall JC, Penrose JF, Weller PF: Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol 2002;109:975-979.
17. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K, Sakamoto T: Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 1998;53:835-841.
18. Yoshida S, Ishizaki Y, Shoji T, Onuma K, Nakagawa H, Nakabayashi M, Akahori K, Hasegawa H, Amayasu H: Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy 2000;30:1008-1014.
19. Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE, Zhang J, Hargreave FE: Montelukast reduces airway eosinophilic inflammation in asthma: a randomized controlled trial. Eur Respir J 1999;14: 12-18.
20. Barnes PJ: Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 1999; 104:S10-S17.
21. Yamaguchi T, Nagata M, Miyazawa H, Kikuchi I, Hagiwara K, Kanazawa M: Tulobuterol, a beta2 agonist, attenuates eosinophil adhesion to endothelial cells. Allergol Int 2005;54:283-288.
22. Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ: Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003;167:1232-1238.
23. Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG: Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003;327:891.
24. Nagata M, Yamamoto H, Shibasaki M, Sakamoto Y, Matsuo H: Hydrogen peroxide augments eosinophil adhesion via beta2 integrin. Immunology 2000;101:412-418.
25. Nagata M, Saito K, Kikuchi I, Hagiwara K, Kanazawa M: Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. Int Arch Allergy Immunol 2005;137:2-6.
26. Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW: Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol 1995;155:2194-2202.
27. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
28. Weller PF: Human eosinophils. J Allergy Clin Immunol 2000;100:283-287.
29. Sedgwick JB, Nagata M: Mechanism of eosinophil activation; in Busse WW, Holgate ST (eds): Asthma and Rhinitis. Boston, Blackwell Scientific, 2000, pp 373-393.
30. Lewis RA, Austen KF, Soberma RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323:645-655.
31. Hamann KJ, Douglas I, Moqbel R: Eosinophil mediators: in Busse WW, Holgate ST (eds): Asthma and Rhinitis, ed 2. Oxford, Blackwell Science, 2000, pp 393-428.
32. Bradley JR, Johnson DR, Pober JS: Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol 1993;142:1598-1609.
33. Nagata M, Sedgwick JB, Kita H, Busse WW: Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol 1998;19:158-166.